Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02028286 · ClinicalTrials.gov registry record · Phase 1
A 21 Day Pharmacokinetics Study in Papulopustular Rosacea
A Phase 1 study, sponsored by Maruho Co..
- Completed
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
NCT02028286: Completed Phase 1 study, sponsored by Maruho Co..
NCT02028286 is a Phase 1 study that has completed, run by Maruho Co.. The registered enrollment target is 25 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (58% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02028286, a Phase 1 study, has completed, sponsored by Maruho Co..
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize the pharmacokinetics of once daily topical gel and confirm that steady state conditions are reached under maximal use conditions following 3 weeks of daily applications.
Primary Outcome
Plasma concentrations of CLS001 to determine pharmacokinetic parameters at visit 2, visit 3 and visit 5.
Interventions
- DRUG CLS001
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2014-01 |
| Phase | Phase 1 |
What the finished NCT02028286 record still lists
NCT02028286 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (58% lower).
The record links to 0 conditions, and to 1 intervention - of which CLS001 is the first listed.
NCT02028286 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02028286 about?
NCT02028286 is a clinical study titled "A 21 Day Pharmacokinetics Study in Papulopustular Rosacea". The purpose of this study is to characterize the pharmacokinetics of once daily topical gel and confirm that steady state conditions are reached under maximal use conditions following 3 weeks of daily applications.
What is the current status of trial NCT02028286?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2014-01.
What interventions are being tested in trial NCT02028286?
The interventions under investigation include: CLS001 (DRUG).
Who is sponsoring clinical trial NCT02028286?
This trial is sponsored by Maruho Co., which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02028286's enrollment target sits among peer trials
25 1495th of 2000 higher than 481 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia